Rocaglamide lipid nanoparticle formulation

We can offer a discount on bulk orders. Please contact our sales team for further inquiry.

Product Infomation

Product Name	Rocaglamide lipid nanoparticle formulation
Catalog Number	LNP-016
Size	10 mg; 20 mg; 50 mg
Alias	Rocaglamide LNP; ROC-A nano-lipid nanoparticles (KHE9A prescription)
Appearance	Milky white to light yellow homogeneous suspension
Solubility	It can be dispersed in physiological buffer (such as PBS)or 5% glucose solution to form a stable colloidal dispersion system
Description	Rocaglamide LNP is a special nano-lipid nanoparticle preparation of the natural anti-tumor compound rocaglamide (ROC-A), which is encapsulated using the systematically screened and optimized formula KHE9A. As a potent eIF4A translation initiation inhibitor, ROC-A can selectively inhibit protein synthesis in a variety of tumor cells. However, its low water solubility, unstable chemical properties, and non-in vitro distribution limit its research application.
Applications	Development of nanodelivery system for eIF4A targeted inhibitors
Storage	4°C, protected from light
Purity	95%+
Shelf Life	1 Year
Shipping Condition	Low temperature transport

Online Inquiry